OxyContin

Judge Delays Purdue Pharma Sentencing Amid Victim Participation Demands

A judge delayed Purdue Pharma’s criminal sentencing to allow victims of the opioid crisis to attend in person, moved by protests outside the courthouse. The sentencing is expected to finalize a $225 million forfeiture by the OxyContin maker, clearing the path for a broader settlement of thousands of lawsuits. This comprehensive agreement includes up to $7 billion from the Sackler family and resolves federal investigations, although some victims continue to advocate for further prosecution.

Read More

Purdue Pharma, Sackler Family to Pay $7.4 Billion in Opioid Settlement

Purdue Pharma and the Sackler family have agreed to a $7.4 billion settlement to resolve lawsuits stemming from the opioid crisis caused by OxyContin. The Sacklers will pay up to $6.5 billion and relinquish company ownership, while Purdue will contribute nearly $900 million. This revised settlement, exceeding the previous offer by $500 million, requires court approval but avoids anticipated federal opposition. The funds will compensate victims, address the opioid crisis, and provide treatment resources.

Read More